tiprankstipranks
Trending News
More News >

Biotage AB Announces Delisting from Nasdaq Stockholm

Story Highlights
Biotage AB Announces Delisting from Nasdaq Stockholm

Don’t Miss TipRanks’ Half-Year Sale

Biotage AB ( (SE:BIOT) ) has provided an update.

Biotage AB has announced its decision to apply for delisting from Nasdaq Stockholm following RWK BidCo AB’s acquisition of over 90% of its shares and initiation of compulsory redemption proceedings for the remaining shares. This strategic move will be followed by an Extraordinary General Meeting on August 7, 2025, to elect new board members, signaling a significant shift in the company’s governance and market presence.

More about Biotage AB

Biotage is a global supplier and solutions partner in the fields of Drug Discovery and Development and Analytical Testing. The company specializes in separation and purification technology and intelligent workflow solutions, aiming to advance health solutions. Headquartered in Sweden, Biotage operates in over 80 countries and is listed on NASDAQ Stockholm.

Average Trading Volume: 803,741

Current Market Cap: SEK11.45B

Learn more about BIOT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1